Friday, July 31, 2026

SK Plasma’s Historic 65 Million EUR Tech Export Deal: What It Means for Turkey’s Pharmaceutical Independence

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.

Roche to Pour $50 Billion into U.S.—And 12,000 New Jobs Are Coming

Roche plans to invest $50 billion in the U.S. over five years, creating over 12,000 jobs and expanding its manufacturing and R&D facilities.

AI MIDDLE EAST LIFELINE: Is The Tesla CEO Betting On Saudi Arabia To Save The AI Dream?

Musk and Huang discussed AI advancements at the U.S.–Saudi Investment Forum, alongside major CEOs and President Trump addressing key sectors.

Tag: obesity

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Novo Nordisk Slashes GLP-1 Drug Prices by Up to 50%: What This Means for Obesity Treatments in 2027

Novo Nordisk will cut prices of GLP-1 treatments in the U.S. by up to 50% from January 2027, amid rising competition and market pressures.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Dark Skin Patches in Teens? It Could Be a Warning Sign, Doctors Say

Dark patches on skin folds in adolescents may indicate Acanthosis Nigricans, linked to obesity and insulin resistance. Consult a specialist.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Underweight People Face Higher Suicide Risk, Study Shows

A study reveals underweight individuals face a higher suicide risk, while overweight individuals show a lower risk, emphasizing BMI's impact.

Study Reveals Semaglutide Reduces Cravings and Helps Control Weight and Blood Sugar

A study shows oral semaglutide aids weight loss and reduces cravings for sugary foods in type 2 diabetes patients.

Could You Have Diabetes? Here’s What You Should Know About the Rising Numbers

In 2022, 14.8% of adults over 30 had diabetes; effective management remains a challenge despite rising awareness and lifestyle changes.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.